• Info
  • Significant Ownership

Significant Ownership of ROCHE FINANCE LTD

Signature - Title
/s/ Carole Nuechterlein - Carole Nuechterlein, Authorized Signatory
Location
Basel Switzerland, Switzerland
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by ROCHE FINANCE LTD.

Notify me when ROCHE FINANCE LTD files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of ROCHE FINANCE LTD

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TRDA Entrada Therapeutics, Inc. Common Stock, $0.0001 par value per share 6.9% $21,041,052 2,569,115 Roche Finance Ltd 31 Dec 2024

Schedules 13D/G Reported by ROCHE FINANCE LTD:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.